Crescent Capital BDC, Inc. (NASDAQ:CCAP) CFO Gerhard Lombard Acquires 1,000 Shares of Stock

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Rating) CFO Gerhard Lombard acquired 1,000 shares of the business’s stock in a transaction on Thursday, May 12th. The shares were purchased at an average cost of $16.89 per share, for a total transaction of $16,890.00. Following the completion of the transaction, the chief financial officer now owns 20,539 shares in the company, valued at approximately $346,903.71. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

CCAP stock opened at $17.01 on Friday. The stock has a market capitalization of $525.44 million, a PE ratio of 6.30, a price-to-earnings-growth ratio of 0.85 and a beta of 0.88. Crescent Capital BDC, Inc. has a 12-month low of $16.58 and a 12-month high of $21.48. The company has a current ratio of 0.80, a quick ratio of 1.37 and a debt-to-equity ratio of 0.96. The stock’s 50 day simple moving average is $17.69 and its 200 day simple moving average is $18.15.

Crescent Capital BDC (NASDAQ:CCAPGet Rating) last announced its earnings results on Wednesday, February 23rd. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $24.14 million during the quarter, compared to analyst estimates of $24.24 million. Crescent Capital BDC had a net margin of 78.46% and a return on equity of 7.88%. On average, research analysts predict that Crescent Capital BDC, Inc. will post 1.66 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 15th. Shareholders of record on Thursday, June 30th will be paid a dividend of $0.41 per share. The ex-dividend date is Wednesday, June 29th. This represents a $1.64 dividend on an annualized basis and a yield of 9.64%. Crescent Capital BDC’s dividend payout ratio is presently 60.74%.

Institutional investors and hedge funds have recently made changes to their positions in the business. Sun Life Financial Inc. increased its stake in Crescent Capital BDC by 62.1% in the 1st quarter. Sun Life Financial Inc. now owns 1,076,654 shares of the company’s stock worth $19,164,000 after buying an additional 412,640 shares in the last quarter. Ares Management LLC increased its stake in Crescent Capital BDC by 54.0% in the 1st quarter. Ares Management LLC now owns 657,838 shares of the company’s stock worth $11,710,000 after buying an additional 230,593 shares in the last quarter. Callodine Capital Management LP boosted its holdings in shares of Crescent Capital BDC by 42.9% during the 3rd quarter. Callodine Capital Management LP now owns 250,000 shares of the company’s stock valued at $4,783,000 after purchasing an additional 75,000 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Crescent Capital BDC by 9.0% during the 4th quarter. BlackRock Inc. now owns 212,168 shares of the company’s stock valued at $3,734,000 after purchasing an additional 17,508 shares during the last quarter. Finally, HighTower Advisors LLC boosted its holdings in shares of Crescent Capital BDC by 5.7% during the 1st quarter. HighTower Advisors LLC now owns 184,285 shares of the company’s stock valued at $3,281,000 after purchasing an additional 9,923 shares during the last quarter. Institutional investors and hedge funds own 54.76% of the company’s stock.

A number of analysts have recently commented on CCAP shares. Wells Fargo & Company dropped their price target on Crescent Capital BDC from $19.50 to $18.50 and set an “overweight” rating on the stock in a research report on Monday, April 25th. Bank of America started coverage on Crescent Capital BDC in a research report on Monday, January 31st. They issued a “buy” rating and a $19.50 price target on the stock. Finally, Zacks Investment Research cut Crescent Capital BDC from a “hold” rating to a “sell” rating in a research report on Tuesday, April 26th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $19.70.

Crescent Capital BDC Company Profile (Get Rating)

Crescent Capital BDC, Inc is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States.

See Also

Insider Buying and Selling by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.